Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,891.00
-36.00 (-1.87%)
At close: Mar 6, 2026
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 352.43 billion as of March 5, 2026. Its market cap has decreased by -6.46% in one year.
Market Cap
352.43B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
36.03
Stock Price
1,891.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 352.43B, an increase of 470.25%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 352.43B | -3.65% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EuBiologics | 488.05B |
| Bukwang Pharmaceutical | 486.91B |
| Dong-A ST | 429.54B |
| FutureChem Co.,Ltd | 414.81B |
| Humedix | 384.94B |
| Huons | 313.43B |
| Korea United Pharm | 293.37B |
| Hyundai Pharmaceutical | 284.25B |